Hims & Hers reports Q3 revenue of $890.4 million, while posting a net loss of $33 million. The company says it is tightening its outlook for 2026 as results reflect weaker profitability despite strong top-line growth.

Both outlets describe a sharp change in margins. Quartz highlights that gross margin falls to 57% from 74% in the third quarter of 2025, framing the quarter as a surprise loss tied to margin compression and a cut to forecast. Fierce Healthcare focuses more on the financial totals and the decision to tighten the 2026 outlook, adding that the net loss is wider than the year-ago period, when the company reported profit.

Together, the coverage presents the same core quarter: strong revenue growth, a net loss, and guidance tightening—differing mainly in emphasis on margin trends versus the outlook and headline figures.